Livzon Pharmaceutical Group Inc. (FRA:LP6)
Germany flag Germany · Delayed Price · Currency is EUR
3.040
-0.040 (-1.30%)
At close: Jan 30, 2026

FRA:LP6 Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Jan '22 Jan '21
3,4394,0633,6103,7254,4724,158
Market Cap Growth
-12.98%12.56%-3.09%-16.70%7.54%16.92%
Enterprise Value
2,7463,2782,8963,0253,7533,397
Last Close Price
3.043.172.412.572.452.27
PE Ratio
13.4114.9014.4814.3818.1919.33
PS Ratio
2.432.602.282.172.683.15
PB Ratio
1.872.061.921.842.262.43
P/TBV Ratio
2.152.302.102.082.562.82
P/FCF Ratio
11.3312.7511.6514.9854.4621.90
P/OCF Ratio
8.9910.318.719.9016.9815.35
EV/Sales Ratio
1.912.101.831.772.252.58
EV/EBITDA Ratio
7.858.038.288.7011.5811.19
EV/EBIT Ratio
8.999.7711.8111.5414.1413.35
EV/FCF Ratio
9.0510.299.3512.1745.7117.89
Debt / Equity Ratio
0.260.270.280.240.190.14
Debt / EBITDA Ratio
1.361.281.501.401.140.80
Debt / FCF Ratio
1.551.651.711.984.541.27
Asset Turnover
0.480.480.500.540.560.55
Inventory Turnover
2.312.092.332.472.742.82
Quick Ratio
1.951.871.861.971.832.13
Current Ratio
2.252.152.132.302.122.40
Return on Equity (ROE)
16.43%15.53%12.78%13.37%13.97%16.45%
Return on Assets (ROA)
6.38%6.40%4.81%5.11%5.58%6.58%
Return on Invested Capital (ROIC)
26.24%26.92%19.70%20.64%25.12%33.56%
Return on Capital Employed (ROCE)
14.70%15.10%11.30%11.10%12.40%14.00%
Earnings Yield
7.46%6.71%6.91%6.95%5.50%5.17%
FCF Yield
8.83%7.85%8.58%6.67%1.84%4.57%
Dividend Yield
4.28%4.58%7.16%8.44%7.36%6.89%
Payout Ratio
48.57%65.03%81.36%83.33%70.81%64.14%
Buyback Yield / Dilution
2.91%1.10%0.56%0.04%0.25%-0.41%
Total Shareholder Return
7.20%5.69%7.72%8.48%7.61%6.49%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.